Ivan Kairatov is a Biopharma expert, with deep knowledge of tech and innovation in the industry and experience in research and development. In this interview, Ivan sheds light on the role of AI in healthcare cybersecurity, highlighting the benefits, adoption rates, future prospects, and the
The dawn of holography technology marks a revolutionary period in healthcare, enhancing diagnostic capabilities, surgical planning, and medical education. With predictions of the global medical holography market reaching $7.11 billion by 2029, the healthcare sector stands on the brink of profound
Ivan Kairatov is a Biopharma expert, with deep knowledge in tech and innovation in the industry and experience in research and development. Today, we will discuss the intricacies of protein kinase research, the role of AI in predicting interactions, and the development of KinasePred. Can you
On March 3, 2025, Faron Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focusing on targeting the CLEVER-1 receptor to reprogram myeloid cells for anti-tumor immunity in both hematological and solid tumors, announced a significant milestone. Their lead therapeutic candidate,
The pharmaceutical industry is abuzz with excitement over a new class of cancer drugs known as PD-1/VEGF inhibitors. These promising therapies, currently undergoing clinical trials, might leapfrog Merck & Co.’s highly successful cancer immunotherapy, Keytruda. The advent of these new drugs c
Parkinson's disease, a devastating neurodegenerative disorder, is characterized by the relentless loss of dopaminergic neurons, which leads to significant motor dysfunction and a decline in overall quality of life. Central to the pathology of PD are aggregates of alpha-synuclein protein and
The University of Manchester recently celebrated a significant milestone with the launch of the British Heart Foundation (BHF) Manchester Center of Research Excellence. Supported by a substantial £4 million grant from the BHF, this new center is set to advance world-class cardiovascular research
The recent announcement by Bayer AG and BlueRock Therapeutics LP marks a significant milestone in the development of cell therapies aimed at vision restoration. The FDA has granted Fast Track designation to OpCT-001, a stem cell therapy designed to treat primary photoreceptor diseases such as
Introducing Ivan Kairatov, a biopharma expert with extensive knowledge in tech and innovation within the industry, and experience in research and development. Today, Ivan will share insights into Netsmart's upcoming showcases and developments in AI and healthcare technology as they prepare for
In the rapidly evolving landscape of biotechnology, the merger of artificial intelligence and drug discovery continues to unlock groundbreaking advances in medical treatments. The latest collaboration between Insilico Medicine and Therasid Bioscience highlights the transformative potential of
